PortfoliosLab logo

Bolt Biotherapeutics, Inc. (BOLT)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$1.63
  • Year Range$1.41 - $18.60
  • EMA (50)$2.24
  • EMA (200)$7.33
  • Average Volume$244.80K
  • Market Capitalization$58.83M

BOLTShare Price Chart


Chart placeholderClick Calculate to get results

BOLTPerformance

The chart shows the growth of $10,000 invested in Bolt Biotherapeutics, Inc. on Feb 8, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $507 for a total return of roughly -94.93%. All prices are adjusted for splits and dividends.


BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

BOLTReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-25.23%-12.57%
YTD-66.73%-18.14%
6M-81.52%-17.07%
1Y-91.29%-5.21%
5Y-90.09%0.29%
10Y-90.09%0.29%

BOLTMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BOLTSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bolt Biotherapeutics, Inc. Sharpe ratio is -0.94. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

BOLTDividend History


Bolt Biotherapeutics, Inc. doesn't pay dividends

BOLTDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

BOLTWorst Drawdowns

The table below shows the maximum drawdowns of the Bolt Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bolt Biotherapeutics, Inc. is 96.47%, recorded on May 6, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.47%Mar 18, 2021288May 6, 2022
-22.7%Feb 11, 202111Feb 26, 20217Mar 9, 202118
-0.51%Mar 15, 20211Mar 15, 20211Mar 16, 20212
-0.2%Mar 10, 20211Mar 10, 20211Mar 11, 20212

BOLTVolatility Chart

Current Bolt Biotherapeutics, Inc. volatility is 126.25%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BOLT (Bolt Biotherapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Bolt Biotherapeutics, Inc.


Loading data...

More Tools for Bolt Biotherapeutics, Inc.